Leukocyte Trafficking in Lymphatic Vessels.


Journal

Cold Spring Harbor perspectives in medicine
ISSN: 2157-1422
Titre abrégé: Cold Spring Harb Perspect Med
Pays: United States
ID NLM: 101571139

Informations de publication

Date de publication:
03 10 2022
Historique:
pmc-release: 01 10 2024
pubmed: 6 4 2022
medline: 6 10 2022
entrez: 5 4 2022
Statut: epublish

Résumé

To ensure proper immune function, most leukocytes constantly move within tissues or between them using the blood and lymphatic vessels as transport routes. While afferent lymphatic vessels transfer leukocytes from peripheral tissues to draining lymph nodes (dLNs), efferent lymphatics return lymphocytes from LNs back into the blood vascular circulation. Over the last decades, great progress has been made in our understanding of leukocyte migration into and within the lymphatic compartment, leading to the approval of new drugs targeting this process. In this review, we first introduce the anatomy of the lymphatic vasculature and the main cell types migrating through lymphatics. We primarily focus on dendritic cells (DCs) and T cells, the most prominent lymph-borne cell types, and discuss the functional significance as well as the main molecules and steps involved in their migration. Additionally, we provide an overview of the different techniques used to study lymphatic trafficking.

Identifiants

pubmed: 35379657
pii: cshperspect.a041186
doi: 10.1101/cshperspect.a041186
pmc: PMC9524389
pii:
doi:

Types de publication

Journal Article Review Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2022 Cold Spring Harbor Laboratory Press; all rights reserved.

Auteurs

Aline Bauer (A)

Institute of Pharmaceutical Sciences, ETH Zurich, CH-8093 Zurich, Switzerland.

Hazal Tatliadim (H)

Institute of Pharmaceutical Sciences, ETH Zurich, CH-8093 Zurich, Switzerland.

Cornelia Halin (C)

Institute of Pharmaceutical Sciences, ETH Zurich, CH-8093 Zurich, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH